Gynecologic Oncologist @MDAndersonNews. Opinions are my own. @Geiselmed, @HarvardMed alum. Girl mom and Poodle enthusiast dog mom x2. She/Her
Joined March 2021
- Tweets94
- Following139
- Followers245
- Likes336
Roni Nitecki Wilke retweeted
Read now in #JCO: Facilitated Cascade Genetic Testing for Relatives of Individuals With BRCA1/2 Pathogenic Variants: A Randomized Controlled Trial.
bit.ly/4hBoVXt
Roni Nitecki Wilke retweeted
Knowing your inherited cancer risk is just the first step. A UT MD Anderson study published in @JCO_ASCO found personalized support increased BRCA1/BRCA2 testing among at-risk first-degree relatives from 51% to 73% in six months.
Read more: spr.ly/6015BGSUiL #EndCancer @NiteckiRoni
Excited to share our randomized controlled trial published in @JCO_ASCO showing that facilitated cascade testing increased genetic testing among relatives of individuals with BRCA1/2. @RauhHainMD @karenluMD @headofmelon @UTMDAnderson @MelissaFrey2
🔗 ascopubs.org/doi/full/10.120…
Roni Nitecki Wilke retweeted
@NiteckiRoni @MDAndersonnews highlights how streamline medically directed #cascadetesting for #BRCA carriers leads to ⬆️ familial compliance of follow through 🧬 testing by family members. Scaled implementation takes time. HOW we deliver #gyncancancer care matters!
Roni Nitecki Wilke retweeted
Fantastic work @NiteckiRoni @MDAndersonnews Facilitated cascade #genetictesting improved testing in families of #BRCA carriers. #SGOAM2026 @gynoncjnls #gyncsm
Roni Nitecki Wilke retweeted
Up to 80% of people with hereditary cancer risk remain unidentified, a critical missed cancer prevention opportunity.
At the #SGOAM26 Plenary, Roni Nitecki Wilke, MD (@NiteckiRoni @UTMDAnderson) presents data comparing facilitated cascade testing vs. standard care in families with BRCA1/2 mutations to help close this gap.
Key takeaways:
• Facilitated cascade testing significantly increases completion rates vs. standard approaches, with no impact on quality of life.
• Supports a new standard of care, with need for scalable models.
Roni Nitecki Wilke retweeted
Excited about our JAMA Oncology study! Adding CHT to RT showed no OS benefit in intermediate-risk cervical cancer, aligning with GOG 263 (#SGO2025). Hope this helps refine guidelines & improve patient care.
@dviverosc @headofmelon @NiteckiRoni @RParejaGineOnco @RauhHainMD
Adding chemotherapy to radiotherapy was not associated with improved overall survival for patients with intermediate-risk cervical cancer. ja.ma/4kATTzM @nagustiga
Roni Nitecki Wilke retweeted
Our 15-year cohort study explores trends in surgical de-escalation in gynecologic oncology. These findings are transforming patient care but raise important questions about the preparation of fellows in surgical training.
@headofmelon @dviverosc @RauhHainMD @NiteckiRoni
Gynecologic oncology is moving towards less invasive surgical methods and decreased surgery overall, which likely benefits patients but also raises challenges for surgical training and the equitable access. ja.ma/3DNOWmf
Roni Nitecki Wilke retweeted
Excited to share my latest publication in the @IJGConline
Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery ijgc.bmj.com/content/early/2…
@karenluMD @NiteckiRoni
#cancer during #pregnancy is associated with severe maternal and neonatal morbidity. Proud of the entire team for this important manuscript!
authors.elsevier.com/c/1k7m2…
@RauhHainMD @headofmelon @markaclapp @abigailflynt @dviverosc @nagustiga @MDAndersonNews @AJOG_thegray
Roni Nitecki Wilke retweeted
#LeadArticle Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare by @AnneKniselyMD
🔎 bit.ly/4hAl1xq
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Jc_vilches @erodriguezglez @daggezmine @astraubhar @raikhanbo
Roni Nitecki Wilke retweeted
Check out the November #IJGCclub! On the 20th, the @IJGConline editors & fellows will speak with @AnneKniselyMD & @NiteckiRoni about their article on racial & socioeconomic disparities in the use of targeted therapies for advanced #ovariancancer.
We look forward to the discussion!
Read their article 👉ijgc.bmj.com/content/34/11/1…
Register for the event 👉esgo.org/zoom-journal-club/
#gynonc @ENYGO_official #oncoalert
Roni Nitecki Wilke retweeted
📣 Join @NiteckiRoni and @AnneKniselyMD as they explore the critical issue of #Racial & #Sociodemographic #Disparities in Novel #Therapeutics on our latest podcast episode.
🎧✨ Don't miss out—tune in now! 👉 bit.ly/4fc9wdE
#HealthcareEquity #NovelTherapeutics
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @Jc_vilches @erodriguezglez @daggezmine @astraubhar
#IJGConline #Research #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc
Roni Nitecki Wilke retweeted
Huge congratulations to our @MDAndersonNews graduating fellows @HanTCun @jahow514 @NiteckiRoni !!! Proud of all you have accomplished, grateful for your dedication, and here to support you in your new roles!!! #oncsurgery @aaronshafer99
Roni Nitecki Wilke retweeted
Pics of @NiteckiRoni on her first and last day at LBJ! Congrats to @NiteckiRoni, @jahow514 and @HanTCun on their upcoming fellowship graduation! We are so proud of you and honored to have been part of your training @aaronshafer99 @maonstad @karenluMD #OncSurgery – at Houston, TX
Roni Nitecki Wilke retweeted
I can’t think of a better place for #teambuilding and #wellness with our @MDAndersonNews Gyn Onc fellows and colleagues! #17miledrive #pebblebeach #oncsurgery
Roni Nitecki Wilke retweeted
Beautiful weekend in Monterey at #WAGO2023 #FelixRutledgeSociety meeting with our current and former @MDAndersonNews colleagues and friends! #endcancer #oncsurgery – at Monterey, CA
Roni Nitecki Wilke retweeted
Congratulations to our superstar graduating @MDAndersonNews Gyn Onc fellows Drs. How, Wilke, and Cun! 👏🏻🎉❤️ #endcancer #oncsurgery – at Monterey, CA
Roni Nitecki Wilke retweeted
Exciting data from the SOLAR trial presented by @ShannonWestin on the use of combination PARPi and MEKi for RAS mutated recurrent ovarian and endometrial cancer! #SGOmtg #oncsurgery @MDAndersonNews
Roni Nitecki Wilke retweeted
.@ShannonWestin @MDAndersonNews presenting neoadjuvant Olaparib study in #BRCA mutated #ovariancancer @SGO_org #SGOMtg #sgo2023 #oncsurgery #gyncsm
